Annual CFF
-$2.13 M
-$200.60 K-10.41%
December 31, 2023
Summary
- As of February 7, 2025, IPHA annual cash flow from financing activities is -$2.13 million, with the most recent change of -$200.60 thousand (-10.41%) on December 31, 2023.
- During the last 3 years, IPHA annual CFF has fallen by -$784.20 thousand (-58.34%).
- IPHA annual CFF is now -102.44% below its all-time high of $87.06 million, reached on December 31, 2019.
Performance
IPHA Cash From Financing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash From Financing Formula
CFF = Cash Inflows from Financing Activities − Cash Outflows from Financing Activities
IPHA Cash From Financing Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -10.4% | - | - |
| 3 y3 years | -58.3% | - | - |
| 5 y5 years | -102.9% | - | - |
IPHA Cash From Financing Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -106.7% | at low | ||||
| 5 y | 5-year | -102.4% | at low | ||||
| alltime | all time | -102.4% | +28.5% |
Innate Pharma SA Cash From Financing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2023 | -$2.13 M(+10.4%) | - | - |
| Dec 2022 | -$1.93 M(-106.1%) | - | - |
| Dec 2021 | $31.73 M(-2460.6%) | - | - |
| Dec 2020 | -$1.34 M(-101.5%) | - | - |
| Dec 2019 | $87.06 M(+20.4%) | - | - |
| Dec 2018 | $72.29 M(+6876.6%) | - | - |
| Dec 2017 | $1.04 M(-255.5%) | - | - |
| Dec 2016 | -$666.30 K(-119.8%) | - | - |
| Dec 2015 | $3.36 M(-94.7%) | - | - |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2014 | $63.77 M(+144.0%) | - | - |
| Dec 2013 | $26.13 M(-977.7%) | - | - |
| Dec 2012 | -$2.98 M(+224.0%) | - | - |
| Dec 2011 | -$918.90 K(-22.4%) | - | - |
| Dec 2010 | -$1.18 M(-103.8%) | - | - |
| Dec 2009 | $31.46 M(+3340.3%) | - | - |
| Dec 2008 | $914.40 K(+5.7%) | - | - |
| Dec 2007 | $865.10 K(-98.4%) | - | - |
| Dec 2006 | $53.04 M(>+9900.0%) | - | - |
| Dec 2005 | $309.90 K | - | - |
FAQ
- What is Innate Pharma SA annual cash flow from financing activities?
- What is the all time high annual CFF for Innate Pharma SA?
- What is Innate Pharma SA annual CFF year-on-year change?
What is Innate Pharma SA annual cash flow from financing activities?
The current annual CFF of IPHA is -$2.13 M
What is the all time high annual CFF for Innate Pharma SA?
Innate Pharma SA all-time high annual cash flow from financing activities is $87.06 M
What is Innate Pharma SA annual CFF year-on-year change?
Over the past year, IPHA annual cash flow from financing activities has changed by -$200.60 K (-10.41%)